Dedicare Resultados de beneficios anteriores

Pasado controles de criterios 3/6

Dedicare ha aumentado sus beneficios a una tasa media anual de 31.5%, mientras que los beneficios de la industria de Healthcare han experimentado un crecimiento de 31.9% anual. Los ingresos han ido creciendo a una tasa media de 23.3% al año. La rentabilidad financiera de Dedicare es de 29.6%, y sus márgenes netos son de 5.1%.

Información clave

31.5%

Tasa de crecimiento de los beneficios

30.6%

Tasa de crecimiento del BPA

Crecimiento de la industria Healthcare	8.1%
Tasa de crecimiento de los ingresos	23.3%
Rentabilidad financiera	29.6%
Margen neto	5.1%
Próxima actualización de resultados	12 Jul 2024

Actualizaciones de resultados anteriores recientes

We Think Dedicare's (STO:DEDI) Solid Earnings Are Understated

Feb 16

Recent updates

Dedicare (STO:DEDI) Is Paying Out A Larger Dividend Than Last Year

Apr 25

Dedicare (STO:DEDI) Has Announced That It Will Be Increasing Its Dividend To SEK6.50

Feb 22

Dedicare AB (publ)'s (STO:DEDI) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Feb 22

We Think Dedicare's (STO:DEDI) Statutory Profit Might Understate Its Earnings Potential

Feb 02

Would Shareholders Who Purchased Dedicare's (STO:DEDI) Stock Three Years Be Happy With The Share price Today?

Jan 14

Would Dedicare AB (publ) (STO:DEDI) Be Valuable To Income Investors?

Dec 27

Our Take On The Returns On Capital At Dedicare (STO:DEDI)

Dec 06

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero Dedicare. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

OM:DEDI Ingresos, gastos y beneficios (SEK Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
31 Mar 24	1,900	96	200
31 Dec 23	1,973	110	200
30 Sep 23	2,011	102	28
30 Jun 23	1,937	102	24
31 Mar 23	1,882	105	140
31 Dec 22	1,772	101	180
30 Sep 22	1,623	93	55
30 Jun 22	1,504	84	36
31 Mar 22	1,379	76	18
31 Dec 21	1,250	66	0
30 Sep 21	1,143	61	139
30 Jun 21	1,063	55	114
31 Mar 21	980	42	92
31 Dec 20	885	36	70
30 Sep 20	823	29	62
30 Jun 20	783	23	62
31 Mar 20	762	26	62
31 Dec 19	776	26	62
30 Sep 19	784	28	65
30 Jun 19	794	31	65
31 Mar 19	803	32	65
31 Dec 18	812	38	65
30 Sep 18	812	42	61
30 Jun 18	787	43	61
31 Mar 18	778	50	61
31 Dec 17	785	60	61
30 Sep 17	781	68	53
30 Jun 17	759	72	53
31 Mar 17	716	65	53
31 Dec 16	650	53	53
30 Sep 16	603	42	149
30 Jun 16	585	33	149
31 Mar 16	573	30	149
31 Dec 15	573	30	149
30 Sep 15	567	31	0
30 Jun 15	548	31	0
31 Mar 15	523	28	0
31 Dec 14	498	23	0
30 Sep 14	482	17	0
30 Jun 14	468	14	0
31 Mar 14	467	13	0
31 Dec 13	469	14	0
30 Sep 13	486	15	1
30 Jun 13	507	17	1

Ingresos de calidad: DEDI tiene ganancias de alta calidad.

Margen de beneficios creciente: Los actuales márgenes de beneficio(5.1%) de DEDI son inferiores a los del año pasado (5.6%).

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: En los últimos 5 años, los beneficios de lDEDI han crecido significativamente en un 31.5% al año.

Acelerando crecimiento: DEDI ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.

Beneficios vs. Industria: DEDI tuvo un crecimiento negativo de los beneficios (-8.4%) durante el año pasado, lo que dificulta la comparación con la media de la industria Healthcare (9%).

Dedicare Resultados de beneficios anteriores

Pasado controles de criterios 3/6

Información clave

Actualizaciones de resultados anteriores recientes

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

We Think Dedicare's (STO:DEDI) Solid Earnings Are Understated

Dedicare AB (publ) to Report Fiscal Year 2023 Results on Mar 22, 2024

Dedicare AB (publ) to Report First Half, 2024 Results on Jul 12, 2024

Third quarter 2023 earnings: Revenues exceed analyst expectations

Second quarter 2023 earnings released

Recent updates

Independent Director recently bought kr166k worth of stock

Investor sentiment deteriorates as stock falls 31%

Dedicare (STO:DEDI) Is Paying Out A Larger Dividend Than Last Year

Upcoming dividend of kr6.50 per share

Full year 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Dedicare (STO:DEDI) Has Announced That It Will Be Increasing Its Dividend To SEK6.50

We Think Dedicare's (STO:DEDI) Solid Earnings Are Understated

Dividend increased to kr6.50

Dedicare AB (publ) to Report Fiscal Year 2023 Results on Mar 22, 2024

Dedicare AB (publ) to Report First Half, 2024 Results on Jul 12, 2024

Here's Why We Think Dedicare (STO:DEDI) Might Deserve Your Attention Today

Dedicare AB (Publ) Proposes Dividend for the Financial Year 2023

What Does Dedicare AB (publ)'s (STO:DEDI) Share Price Indicate?

Third quarter 2023 earnings: Revenues exceed analyst expectations

New minor risk - Market cap size

Second quarter 2023 earnings released

Investor sentiment deteriorates as stock falls 20%

Chairman recently sold kr4.7m worth of stock

Investor sentiment deteriorates as stock falls 17%

Less than half of directors are independent

Investor sentiment deteriorates as stock falls 16%

First quarter 2023 earnings released

Upcoming dividend of kr6.00 per share at 3.9% yield

Is Dedicare (STO:DEDI) A Risky Investment?

Full year 2022 earnings: EPS in line with analyst expectations despite revenue beat

Investor sentiment improved over the past week

Price target increased to kr103

Insufficient new directors

Third quarter 2022 earnings: Revenues in line with analyst expectations

Does Dedicare (STO:DEDI) Deserve A Spot On Your Watchlist?

Insufficient new directors

Dedicare AB (publ) (OM:DEDI) signed an agreement to acquire Templars Medical Agency (Uk) Limited for £1.8 million.

Dedicare (STO:DEDI) Seems To Use Debt Rather Sparingly

Second quarter 2022 earnings: Revenues exceed analyst expectations

If You Like EPS Growth Then Check Out Dedicare (STO:DEDI) Before It's Too Late

Investor sentiment improved over the past week

First quarter 2022 earnings: EPS and revenues miss analyst expectations

First quarter 2022 earnings: Revenues miss analyst expectations

Upcoming dividend of kr4.00 per share

Dedicare (STO:DEDI) Could Be Struggling To Allocate Capital

Here's Why We Think Dedicare (STO:DEDI) Is Well Worth Watching

Full year 2021 earnings: EPS and revenues miss analyst expectations

I Ran A Stock Scan For Earnings Growth And Dedicare (STO:DEDI) Passed With Ease

A Look At The Fair Value Of Dedicare AB (publ) (STO:DEDI)

Third quarter 2021 earnings released

Investor sentiment improved over the past week

I Ran A Stock Scan For Earnings Growth And Dedicare (STO:DEDI) Passed With Ease

Be Wary Of Dedicare (STO:DEDI) And Its Returns On Capital

Second quarter 2021 earnings released

A Look At The Intrinsic Value Of Dedicare AB (publ) (STO:DEDI)

First quarter 2021 earnings released: EPS kr1.02 (vs kr0.42 in 1Q 2020)

Upcoming dividend of kr2.50 per share

Should Dedicare AB (publ) (STO:DEDI) Be Part Of Your Dividend Portfolio?

Dedicare (STO:DEDI) Could Easily Take On More Debt

What Do The Returns On Capital At Dedicare (STO:DEDI) Tell Us?

Dedicare AB (publ)'s (STO:DEDI) Stock is Soaring But Financials Seem Inconsistent: Will The Uptrend Continue?

Full year 2020 earnings released: EPS kr3.84 (vs kr2.92 in FY 2019)

We Think Dedicare's (STO:DEDI) Statutory Profit Might Understate Its Earnings Potential

Investor sentiment improved over the past week

Would Shareholders Who Purchased Dedicare's (STO:DEDI) Stock Three Years Be Happy With The Share price Today?

New 90-day high: kr41.40

Would Dedicare AB (publ) (STO:DEDI) Be Valuable To Income Investors?

Our Take On The Returns On Capital At Dedicare (STO:DEDI)

Third quarter earnings released

New 90-day high - kr38.00

Desglose de ingresos y gastosBeta

Historial de beneficios e ingresos

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Desglose de ingresos y gastos
Beta